FDA has issued draft guidance on the de novo device classification process, indicating that the agency will allow manufacturers to submit devices for de novo classification at the same time as they ...
The Sensible Classification Act would codify classification authority, streamline declassification, invest in new technology for classification reviews and require an evaluation of existing security.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback